At 10.5% CAGR, Asia-Pacific Point-of-Care Testing (POCT) Market Worth US$ 64.46 Billion by 2029

Asia-Pacific Point-of-Care Testing (POCT) market research report, principal attributes such as highest level of spirit, practical solutions, dedicated research and analysis, innovation, talent solutions, integrated approaches, most advanced technology and commitment plays a key role. All of these features are strictly applied while building this market report for a client. It presents a definite solution to obtain market insights with which businesses can think about market place clearly and thereby take important decisions for growth of the business. The universal Asia-Pacific Point-of-Care Testing (POCT) market report includes all the company profiles of the major players and brands.

Asia-Pacific Point-of-Care Testing (POCT) marketing report describes in-depth and comprehensive market study along with current and forthcoming opportunities that emphasizes the future market investment. It becomes simple to illustrate the commerce strategies for the businesses of small, medium as well as large size with the help of this Asia-Pacific Point-of-Care Testing (POCT) report. The market insights obtained through this market research eases the understanding of the market landscape, related issues that may interrupt in the future, and ways to position specific brand brilliantly. Deliberately analyzed facts and figures of the healthcare industry and powerful business insights mentioned in the persuasive Asia-Pacific Point-of-Care Testing (POCT) report are the key aspects to achieve a long-term business growth.

Download Sample PDF Copy of this Report to understand structure of the complete report (Including Full TOC, Table & Figures) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=apac-point-care-testing-poct-market

Leading Key Players Operating in the Asia-Pacific Point-of-Care Testing (POCT) Market Includes:

Abbott (U.S)
Hoffmann-La Roche Ltd (Switzerland)
BD (U.S)
Siemens Healthcare Private Limited (Germany)
Bio-Rad Laboratories, Inc. (U.S)
Danaher (U.S)
Sekisui Diagnostics (U.S)
Trinity Biotech (Ireland)
bioMerieux (France)
EKF Diagnostics (Germany)
AccuBioTech Co., Ltd. (China)

Key Market Analysis and Insights:

Point-of-care testing, which is defined as testing that may be done in close proximity to the patient and allows a medical choice to be taken right away based on the results and monitoring. point-of-care testing (POCT), also known as with-patient testing, allows doctors to assess accurate real-time, lab-quality diagnostic results in minutes rather than hours. It guarantees that patients get the most effective and efficient care possible, whenever and wherever they need it.

Data Bridge Market Research analyses that the point-of-care testing (POCT) market which was USD 29 billion in 2021, would rocket up to USD 64.46 billion by 2029, and is expected to undergo a CAGR of 10.5% during the forecast period 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Point-of-Care Testing (POCT) Market Regional Analysis/Insights:

The point-of-care testing (POCT) market is analysed and market size insights and trends are provided by country, product, technology, prescription, application end-user and distribution channel as referenced above.

The countries covered in the point-of-care testing (POCT) market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).

China is expected to dominate the market because point-of-care testing (POCT) products in China have a massive application space in the fields of hospital operation, emergency department, intensive care, chronic disease prevention and control, public health emergencies, county-level medical institution construction, and new rural supportive medical care.

Japan will dominate the market due to an increasing number of people suffering from HIV and other illnesses, which will result in a high approval rate for point-of-care testing devices in the country. India is the dominant country due to the high prevalence of diseases among its people.

Browse Full Report Along With Facts and Figures @ https://www.databridgemarketresearch.com/reports/apac-point-care-testing-poct-market

Point-of-Care Testing (POCT) Market Dynamics:-

Drivers:

Upward trend in disease prevalence in the developing countries
Chronic diseases and acute infections are on the rise in developing countries, owing to a lack of health awareness, poor medical infrastructure, and a sedentary lifestyle, among other causes. As a result of these circumstances, diagnosis and treatment are delayed, as is the quality of care obtained. The need for point-of-care tests for rapid diagnosis is growing due to their convenience of use, cost-effectiveness, and small product size.

Benefits related with OTC-based test
The point of care testing market for TC tests is expected to develop at a 7.1% CAGR through 2027, owing to an increase in OTC testing such as pregnancy tests and blood glucose tests that deliver results in a matter of seconds. These examinations do not necessitate the use of a skilled specialist and may be performed by individuals themselves, propelling the industry forward. The First Response kit, for example, is a quick pregnancy test that provides a response in 60 seconds. Accu-Chek active blood glucose metre kits also give customers with readings in 5 seconds, boosting market demand.

Increasing incidence rate of diabetes and obesity lead to cardiovascular illness
The increased prevalence of diabetes and obesity, the point of care testing market for cardio metabolic testing is predicted to exceed USD 5.3 billion by 2027. The cardiometabolic test also determines the percentage level of Docosahexaenoic acid (DHA) and eicosapentanoic acid (EPA) in red blood cell membrane.This also aids in the identification of new risk factors for cardiac arrest and other heart-related disorders.

Table of Contents: Asia-Pacific Point-of-Care Testing (POCT) Market

1 Introduction
2 Market Segmentation
3 Market Overview
4 Executive Summary
5 Premium Insights
6 Asia-Pacific Point-of-Care Testing (POCT) Market, By Type
7 Asia-Pacific Point-of-Care Testing (POCT) Market, By Tumor Type
8 Asia-Pacific Point-of-Care Testing (POCT) Market, By Application
9 Asia-Pacific Point-of-Care Testing (POCT) Market, By End User
0 Asia-Pacific Point-of-Care Testing (POCT) Market, By Geography
11 Asia-Pacific Point-of-Care Testing (POCT) Market, Company Landscape
12 Company Profiles
13 Related Reports

Check Complete Table of Contents with List of Table and Figures @ https://www.databridgemarketresearch.com/toc/?dbmr=apac-point-care-testing-poct-market

Asia-Pacific Point-of-Care Testing (POCT) Market Scope:-

The point-of-care testing (POCT) market is segmented on the basis of product, technology, prescription, application, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product:
Glucose Monitoring
Strips
Meters
Lancets
Cardiometabolic testing
Cardiac marker testing
hsTnl
BNP
D-dimer
CK-MB
Myoglobin
Others
Blood gas/electrolytes testing
HBA1C testing

Application:
Cardio metabolic testing
Infectious disease testing
Nephrology testing
Drug-of-Abuse (DoA) testing
Blood glucose testing
Pregnancy testing
Cancer biomarker testing
Other applications

End-user:
Hospitals
Diagnostic centers
Research laboratories
Home-care settings
Others

Distribution Channel:
Direct tender
Retail Pharmacies

Inquire Before Buying This Research Report@ https://www.databridgemarketresearch.com/inquire-before-buying/?dbmr=apac-point-care-testing-poct-market

Top Trending Reports of Healthcare Industry:

https://www.databridgemarketresearch.com/reports/global-hybrid-imaging-market
https://www.databridgemarketresearch.com/reports/global-organ-function-assays-market
https://www.databridgemarketresearch.com/reports/global-galectin-inhibitor-therapeutics-market
https://www.databridgemarketresearch.com/reports/global-spinal-cord-tumor-market
https://www.databridgemarketresearch.com/reports/global-tumor-transcriptomics-market
https://www.databridgemarketresearch.com/reports/global-ultrasound-probe-market
https://www.databridgemarketresearch.com/reports/global-tropical-disease-testing-products-market
https://www.databridgemarketresearch.com/reports/global-chronic-spontaneous-urticaria-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:-

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com

This release was published on openPR.